all presentations
Featuring : Reiner Laus, M.D., EVP and President, Cancer Vaccines, Bavarian Nordic, and CEO & President, BN ImmunoTherapeutics.
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.
Featuring : M. Stephen Simes, Vice-Chairman, President and Chief Executive Officer, BioSante
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.
Featuring : Mark L. Bagarazzi, MD Chief Medical Officer
Featuring : Craig Dees, PhD, Chief Executive Officer, Provectus Pharmaceuticals Inc., (PVCT.OB)
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.
Featuring : Thomas Davis, MD, Senior Vice President and Chief Medical Officer, Celldex, Inc. (NASDAQ:CLDX)
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.
Featuring : Manish Singh, PhD, President & Chief Executive Officer, ImmunoCellular Therapeutics, Ltd., (OTC:IMUC.OB)
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.
Featuring : Marnix L Bosch, PhD, Chief Technical Officer, Northwest Bioterapeutics, Inc., (OTC:NWBO).
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.
Featuring : Timothy A. Wurst, MBA, Vice President for Clinical Research and Regulatory Affairs, TVAX Biomedical, LLC.
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.
Featuring : Frederick M. Miesowicz, PhD, Chief Operating Officer, Argos Therapeutics.
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.
Dendreon Presentation at Cancer Immunotherapy Conference
Featuring : David L. Urdal, PhD, Chief Scientific Officer, Dendreon
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.